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Many factors, including hyperglycemia, hypertension, obesity, dyslipidemia, and a
sedentary lifestyle, contribute to a high prevalence of cardiovascular disease. Specific
vascular impairment treatments in the context of diabetes and vascular risk need to be
improved. Salidroside is the primary active component of Rhodiola rosea and has
documented antioxidative, cardioprotective, and vasculoprotective properties. The aim
of this study was to test the hypothesis that salidroside has protective effects against
hyperglycemia, hypertension, and vasodilation impairment in the Goto-Kakizaki (GK)
rat model of diabetes. We evaluated cardiovascular parameters (e.g.,
daytime/nighttime systolic and diastolic blood pressure, heart rate, and activity),
metabolic parameters (e.g., body weight, food and water consumption, serum
fructosamine level, glucose tolerance), eNOS / phospho-eNOS expression level and in
vitro vascular reactivity of aorta and second-order mesenteric arteries in Wistar-Kyoto
(control) and GK (diabetic) rats treated with salidroside (40 mg/kg) or placebo (water)
for 5 weeks. GK rats showed hypertension, marked glucose intolerance, and impaired
endothelium-dependent and endothelium-independent vasodilation capacity.
Salidroside showed beneficial effects on endothelial and non-endothelial vasodilation
and likely acts on the endothelium and smooth muscle cells through the soluble
guanylyl cyclase pathway. Despite its vascular effects, salidroside had no effect on
blood pressure and heart rate in GK and control rats, it did not improve glucose
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